Los Angeles, CA, United States of America

Eli Gang

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 2.8

ph-index = 5

Forward Citations = 426(Granted Patents)


Location History:

  • Beverly Hills, CA (US) (2011)
  • Los Angeles, CA (US) (2000 - 2023)

Company Filing History:


Years Active: 2000-2025

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Eli Gang: Innovator in Cardiac Technology

Introduction

Eli Gang is a prominent inventor based in Los Angeles, California, known for his significant contributions to cardiac technology. With a total of 10 patents to his name, he has made remarkable advancements in the field of pacemaker systems and hypertension treatment.

Latest Patents

One of Eli Gang's latest patents is an "Intelligently, continuously and physiologically controlled pacemaker and method of operation of the same." This innovative pacemaker control system incorporates both internal and external sensors, along with a circuit for entering patient reports. The system utilizes artificial intelligence to process data from these sensors, enabling it to learn and optimize pacemaker function for individual patients. Another notable patent is the "Method of treatment of drug-resistant hypertension," which involves right atrial pacing to stimulate heart tissue and reduce blood pressure through a closed-loop system.

Career Highlights

Eli Gang has worked with several companies throughout his career, including Magnetecs Corporation and Neuro-Kinesis Inc. His work has focused on developing advanced medical devices that enhance patient care and improve health outcomes.

Collaborations

Eli has collaborated with notable professionals in his field, including Yehoshua Shachar and Laszlo Farkas. These partnerships have contributed to the success of his innovative projects and patents.

Conclusion

Eli Gang's work in cardiac technology exemplifies the impact of innovation in healthcare. His patents and collaborations continue to pave the way for advancements in medical devices, ultimately benefiting patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…